B.C. Nasal Naloxone Access Delayed by Bureaucracy

Internal ministry documents obtained via freedom of information reveal that British Columbia's Ministry of Health held urgent discussions in December 2025 concerning the expansion of free nasal naloxone access. These emails followed significant media coverage and calls from experts and the opposition to broaden the program, which had been delayed in its evaluation release.

The pilot program, initially launched in May 2024 for priority populations, was expanded in July 2025 to include anyone at risk. However, the timing of the internal briefing suggests that the decision to make nasal naloxone free to all British Columbians, announced in February 2026, was significantly influenced by public and media pressure.

Critics, including the B.C. Conservative Critic for Mental Health and Addictions, expressed concern that the response appeared reactionary. Similarly, a physician from Doctors for Safer Drug Policy noted it was "heartbreaking" that a briefing was prompted by media attention rather than the severity of the public health emergency.

Despite the rollout of broader access to nasal naloxone this week, allowing it to be stocked alongside injectable naloxone at over 2,400 locations, questions remain about the program's evaluation. The Ministry of Health stated that supply for pilots was distributed through early 2026 and findings informed the integration, but specific evaluation data prior to the December 2025 briefing was not provided.

The expanded availability of nasal naloxone comes after calls for action, including following the overdose death of an 18-year-old university student. While advocates welcome the increased access, they emphasize that it highlights a slower-than-necessary response to a decade-long public health emergency. Work is ongoing to ensure accessibility and educate the public on the best naloxone options.